Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
NCT Number: NCT04821297
This clinical trial evaluates the feasibility of a linguistically-tailored mobile intervention, called CervixChat in improving the follow-up of patients with abnormal Papanicolaou (pap) test results. A text messaging program, such as CervixChat may support patients who need a colposcopy.
Looking for future studies?
Notify Me21 year–65 year
Female
Interventional
Not applicable
Philadelphia, Pennsylvania, 19107, United States
PRIMARY OBJECTIVE:
I. To evaluate the feasibility of CervixChat intervention in a mix method design, through participants consent rate and the study completion rate.
SECONDARY OBJECTIVE:
I. To evaluate the acceptability of CervixChat intervention using a validated Likert-scale participant satisfaction questionnaire, as well as participant's interview data.
EXPLORATORY OBJECTIVE:
I. To evaluate the preliminary impact of CervixChat intervention, by comparing the colposcopy appointment adherence rate in the study cohort against a 1:1 matched control sample selected based on matching age, race and ethnicity, from participants at Jefferson Obstetrics and Gynecology (Ob-Gyn) department scheduled for a colposcopy in 2019.
OUTLINE:
Patients receive text messages for 1-2 months before scheduled appointment. Patients also complete a survey at baseline and after standard of care colposcopy and an interview after standard of care colposcopy.
After completion of study, patients are followed up periodically.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Receive messages
Complete survey
Participate in an interview
Time frame: Up to 12 months
Time frame: Up to 12 months
Thomas Jefferson University
Other
An Innovative and Linguistically-Tailored Mobile Intervention to Improve Follow-Up for Abnormal Pap Test Results: CervixChat
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03180294
Adnexal Diseases, Breast Carcinoma
Anaheim, California, United States
View Trial DetailsNCT05795595
Adenocarcinoma, Adenoma
Duarte, California, United States
View Trial DetailsNCT04411849
Cervical Carcinoma, Communicable Diseases
Lexington, Kentucky, United States
View Trial DetailsNCT05105087
Cervical Carcinoma, Female Urogenital Diseases
Philadelphia, Pennsylvania, United States
View Trial Details